Abstract
Background
This study aimed to compare the rates for resolution and improvement of common comorbidities between laparoscopic sleeve gastrectomy (LSG) and laparoscopic adjustable gastric banding. The comorbid conditions included were type 2 diabetes mellitus (DM), hypertension (HTN), hyperlipidemias (LPD), degenerative joint disease (DJD), gastroesophageal reflux disease (GERD), obstructive sleep apnea (OSA), and asthma.
Methods
A retrospective chart review of the patients who underwent LSG or laparoscopic adjustable gastric banding at our institution from July 2004 to July 2007 was performed. The resolution of comorbidities was determined via patient-completed questionnaires and objective data.
Results
Of the 123 patients (29 men and 94 women) reviewed, 49 had undergone LSG, and 74 had undergone laparoscopic adjustable gastric banding. The mean preoperative body mass index (BMI) was 52 kg/m2 for the LSG patients and 44 kg/m2 for the laparoscopic adjustable gastric banding patients. The overall percentages of excess weight loss (%EWL) were respectively 50.6 and 40.3% (P = 0.03) during mean follow-up periods of 15 and 17 months. There was a greater resolution or improvement of DM after LSG (100% vs 46%), HTN (78% vs 48%), and LPD (87% vs. 50%) than after laparoscopic adjustable gastric banding. Other comorbidities resolved or improved at a similar rate.
Conclusions
Although both LSG and laparoscopic adjustable gastric banding resulted in postoperative improvement or resolution of comorbidities associated with obesity, LSG statistically showed a significantly higher rate of resolution or improvement of DM, HTN, and LPD. There was no significant difference between the groups for DJD, GERD, OSA, or asthma.
Similar content being viewed by others
References
Hess DS, Hess DW (1998) Biliopancreatic diversion with a duodenal switch. Obes Surg 8:267–282
Ren CJ, Patterson E, Gagner M (2000) Early results of laparoscopic biliopancreatic diversion with duodenal switch: a case series of 40 consecutive patients. Obes Surg 10:514–523
Regan JP, Inabnet WB, Gagner M, Pomp A (2003) Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient. Obes Surg 13:861–864
Kuzmak LI, Yap IS, McGuire L, Dixon JS, Young MP (1990) Surgery for morbid obesity: using an inflatable gastric band. AORN J 51:1307–1324
Forsell P, Hallberg D, Hellers G (1993) Gastric banding for morbid obesity: initial experience with a new adjustable band. Obes Surg 3:369–374
Suter M, Giusti V, Worreth M, Heraief E, Calmes JM (2005) Laparoscopic gastric banding: a prospective, randomized study comparing the Lap-Band and the SAGB: early results. Ann Surg 241:55–62
Parikh MS, Fielding GA, Ren CJ (2005) U.S. experience with 749 laparoscopic adjustable gastric bands: intermediate outcomes. Surg Endosc 19:1631–1635
Ponce J, Paynter S, Fromm R (2005) Laparoscopic adjustable gastric banding: 1, 014 consecutive cases. J Am Coll Surg 201:529–535
Oria HE, Moorehead MK (1998) Bariatric analysis and reporting outcome system (BAROS). Obes Surg 8:487–499
Ahroni JH, Montgomery KF, Watkins BM (2005) Laparoscopic adjustable gastric banding: weight loss, co-morbidities, medication usage and quality of life at one year. Obes Surg 15:641–647
Muller MK, Wenger C, Schiesser M, Clavien PA, Weber M (2008) Quality of life after bariatric surgery: a comparative study of laparoscopic banding vs bypass. Obes Surg 18:1551–1557
Himpens J, Dapri G, Cadiere GB (2006) A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years. Obes Surg 16:1450–1456
Favretti F, O’Brien PE, Dixon JB (2002) Patient management after LAP-BAND placement. Am J Surg 184:38S–41S
Suter M, Giusti V, Heraief E, Jayet C, Jayet A (1999) Early results of laparoscopic gastric banding compared with open vertical banded gastroplasty. Obes Surg 9:374–380
de Jong JR, van RB, Gooszen HG, Smout AJ, Tiel-Van Buul MM (2009) Weight loss after laparoscopic adjustable gastric banding is not caused by altered gastric emptying. Obes Surg 19:287–292
Bernstine H, Tzioni-Yehoshua R, Groshar D, Beglaibter N, Shikora S, Rosenthal RJ, Rubin M (2009) Gastric emptying is not affected by sleeve gastrectomy: scintigraphic evaluation of gastric emptying after sleeve gastrectomy without removal of the gastric antrum. Obes Surg 19:293–298
Langer FB, Reza Hoda MA, Bohdjalian A, Felberbauer FX, Zacherl J, Wenzl E, Schindler K, Luger A, Ludvik B, Prager G (2005) Sleeve gastrectomy and gastric banding: effects on plasma Ghrelin levels. Obes Surg 15:1024–1029
Busetto L, Segato G, De LM, Foletto M, Pigozzo S, Favretti F, Enzi G (2006) High Ghrelin concentration is not a predictor of less weight loss in morbidly obese women treated with laparoscopic adjustable gastric banding. Obes Surg 16:1068–1074
Karamanakos SN, Vagenas K, Kalfarentzos F, Alexandrides TK (2008) Weight loss, appetite suppression, and changes in fasting and postprandial Ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double-blind study. Ann Surg 247:401–407
Shen R, Dugay G, Rajaram K, Cabrera I, Siegel N, Ren CJ (2004) Impact of patient follow-up on weight loss after bariatric surgery. Obes Surg 14:514–519
Dixon JB, Dixon ME, O’Brien PE (2001) Preoperative predictors of weight loss at 1 year after Lap-Band surgery. Obes Surg 11:200–207
Moon HS, Kim WW, Oh JH (2005) Results of laparoscopic sleeve gastrectomy (LSG) at 1 year in morbidly obese Korean patients. Obes Surg 15:1469–1475
Cottam D, Qureshi FG, Mattar SG, Sharma S, Holover S, Bonanomi G, Ramanathan R, Schauer P (2006) Laparoscopic sleeve gastrectomy as an initial weight-loss procedure for high-risk patients with morbid obesity. Surg Endosc 20:859–863
Baltasar A, Serra C, Perez N, Bou R, Bengochea M, Ferri L (2005) Laparoscopic sleeve gastrectomy: a multipurpose bariatric operation. Obes Surg 15:1124–1128
Almogy G, Crookes PF, Anthone GJ (2004) Longitudinal gastrectomy as a treatment for the high-risk super-obese patient. Obes Surg 14:492–497
Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, Bantle JP, Sledge I (2009) Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 122:248–256
Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K (2004) Bariatric surgery: a systematic review and meta-analysis. JAMA 292:1724–1737
Ponce J, Haynes B, Paynter S, Fromm R, Lindsey B, Shafer A, Manahan E, Sutterfield C (2004) Effect of Lap-Band-induced weight loss on type 2 diabetes mellitus and hypertension. Obes Surg 14:1335–1342
Disclosures
Daniel Herron has an educational grant with Covidien, is a consultant for W.L. Gore, and serves as a medical advisor for Hourglass Technology. Juan J. Omana, Scott Nguyen, and Subhash Kini have no financial ties or conflicts of interest to disclose.
Author information
Authors and Affiliations
Corresponding author
Additional information
Presented at the SAGES 2009 Annual Meeting, April 22–24, 2009, Phoenix, AZ.
Rights and permissions
About this article
Cite this article
Omana, J.J., Nguyen, S.Q., Herron, D. et al. Comparison of comorbidity resolution and improvement between laparoscopic sleeve gastrectomy and laparoscopic adjustable gastric banding. Surg Endosc 24, 2513–2517 (2010). https://doi.org/10.1007/s00464-010-0995-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-010-0995-0